Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › MANKIND

MANKIND

Mankind Pharma Limited
Mid-capPharma ↗

What the six lenses say about MANKIND — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹2318.0
2026-09-08
VWAP · 1Y anchor
₹2320
-0.1% from VWAP
P/E · TTM
50.0×
TTM EPS ₹46.3
52-week range
53%
position low→high
RSI(14)
37
momentum

Own sector index

Pharma ↗
Overweight

1M

+0.4%

3M

+10.5%

1Y

+22.0%

Breadth >EMA21

56%

How MANKIND’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
3.5
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Mid-cap cohortDRaw
TechnicalD438›

The actual numbers

Price vs VWAP (1y)-0.1%
EMA trend stackMixed
Price vs 200-EMA-1.9%
Price vs 50-EMA-4.2%
RSI(14)37
RS vs Nifty 500 · 3M-6.1%
RS vs sector · 3M-12.1%
52-week range53%
Volume vs 30d avg0.48×
Volume vs 60d avg0.45×
ATR(14) · volatility55.6
Bollinger width · vol contraction0.049
FundamentalD866›

The actual numbers

Return on equity (ROE)13.1%
Return on capital (ROCE)13.5%
Operating margin20.8%
Net margin13.6%
Revenue growth · YoY+16.3%
EPS growth · YoY-6.1%
Debt / equity0.39×

Full 8-quarter history in the financials table below.

ValuationD517›

The actual numbers

P/E (TTM)50.0×
TTM EPS₹46.3
52-week range53%
CatalystD962›

The actual numbers

Earnings & momentum63
Capital actions41
Governance101

Every filing in the corporate-announcements panel below.

FlowD350›

The actual numbers

Promoter holding72.7%
Delivery · 30d avg56.1%
Up/down-day asymmetry-2.3pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Mid-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D4 + D3 ) ÷ 2 = 3.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Watch
39
Conviction score 39/100 · avg-decile strength 3.5/10
Conviction score39/100›
TechnicalD4›
FundamentalD8›
ValuationD5›
CatalystD9›
FlowD3›

Policy

Government policy · Pharma

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+0.1pp
-2.9pp
-0.7pp
-4.5pp
+8.7pp
-6.1pp
Nifty 500
Broad-market baseline
-0.0pp
-2.9pp
-1.8pp
-6.1pp
+3.0pp
-11.3pp
Sector
Own-sector index
—
—
-4.6pp
-12.1pp
-10.1pp
-32.1pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

MANKIND daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
2318.00-9.90

Relative strength

RS vs baseline · rebased to 100

MANKIND ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
97.54-0.00

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)2,8933,0773,2303,0793,5703,6973,5673,443
↳ change QoQ—+6.3%+5.0%-4.7%+15.9%+3.6%-3.5%-3.5%
EBITDA (₹cr)782959907683847921919930
EBITDA margin27.0%31.2%28.1%22.2%23.7%24.9%25.8%27.0%
PAT (₹cr)543659385425445520414559
↳ change QoQ—+21.3%-41.6%+10.5%+4.7%+16.9%-20.4%+35.0%
Net margin18.8%21.4%11.9%13.8%12.5%14.1%11.6%16.2%
EPS (₹)13.3916.319.4510.2010.6212.399.9013.43
D/E————————
YoY growth · Mar '26Revenue +11.8% YoYPAT +31.5% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 7 Sep '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 1 Sep '26
    LOWgovernance
    ESOP/ESOS/ESPS
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 31 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 30 Aug '26
    MEDIUMgovernance
    Cessation
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 26 Aug '26
    LOWgovernance
    Other Restructuring
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 26 Aug '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 22 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 Aug '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 17 Aug '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 Aug '26
    HIGHcapital
    Acquisition
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 10 Aug '26
    MEDIUMgovernance
    Appointment
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 10 Aug '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 10 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 4 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 30 Jul '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds MANKIND

Mutual funds holding MANKIND (10)

FundWeightAUM ₹crGrade
SBI Large Cap Reg Gr1.81%55,431
Nippon India Large Cap Bns0.79%54,225
Nippon India Large Cap Instl Bns0.79%54,225
Nippon India Large Cap Dir Bns0.79%54,225
Nippon India Large Cap Gr0.79%54,225
Nippon India Growth Md Cp Reg Gr Bns1.69%50,751
Nippon India Growth Mid Cap Dir Bns1.69%50,751
Nippon India Growth Md Cp Reg Gr PlGrOpt1.69%50,751
HDFC Large Cap Gr1.68%40,198
Axis ELSS Tax Saver Fd Gr1.06%32,592

ETFs holding MANKIND (10)

ETFWeightGrade
Nippon India Nifty Pharma ETF2.82%
DSP Nifty Healthcare ETF2.44%
Axis NIFTY Healthcare ETF2.43%
Aditya BSL Nifty Healthcare ETF2.43%
ICICI Pru Nifty Healthcare ETF2.43%
Motilal Oswal BSE Select IPO ETF2.22%
Mirae Asset Nifty 500 Healthcare ETF2.01%
Motilal Oswal BSE Healthcare ETF1.71%
Kotak Nifty Midcap 50 ETF1.20%
Motilal Oswal Nifty Midcap 100 ETF0.82%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Pharma